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Abstract
Background: The relationship between intestinal epithelial integrity and the development of intestinal disease is of
increasing interest. A reduction in mucosal integrity has been associated with ulcerative colitis, Crohn’s disease and
potentially could have links with colorectal cancer development. The Ussing chamber system can be utilised as
a valuable tool for measuring gut integrity. Here we describe step-by-step methodology required to measure
intestinal permeability of both mouse and human colonic tissue samples ex vivo, using the latest equipment and
software. This system can be modified to accommodate other tissues.
Methods: An Ussing chamber was constructed and adapted to support both mouse and human tissue to measure
intestinal permeability, using paracellular flux and electrical measurements. Two mouse models of intestinal
inflammation (dextran sodium sulphate treatment and T regulatory cell depletion using C57BL/6-FoxP3DTR
mice) were used to validate the system along with human colonic biopsy samples.
Results: Distinct regional differences in permeability were consistently identified within mouse and healthy
human colon. In particular, mice showed increased permeability in the mid colonic region. In humans the left
colon is more permeable than the right. Furthermore, inflammatory conditions induced chemically or due to
autoimmunity reduced intestinal integrity, validating the use of the system.
Conclusions: The Ussing chamber has been used for many years to measure barrier function. However, a
clear and informative methods paper describing the setup of modern equipment and step-by-step procedure
to measure mouse and human intestinal permeability isn’t available. The Ussing chamber system methodology we
describe provides such detail to guide investigation of gut integrity.
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Background
The intestinal epithelial barrier separates luminal con-
tents from the internal body, crucial for maintaining the
symbiotic relationship between the host and intestinal
microbes. It is composed of epithelial cells, linked to-
gether by tight junctional (TJ) protein complexes, re-
quired for sealing the paracellular space [1–3].
Impairment of barrier function has been linked to intes-
tinal diseases such as ulcerative colitis and Crohn’s dis-
ease [4–7]. Gut integrity can be assessed in vivo, by
measuring the presence of molecular probes such as
sugars or dextran in urine or blood after oral intake [8,
9]. Whilst this method can determine overall differences
in permeability between the small and large intestine, it
is unable to reveal detailed information relating to pre-
cise regional locations of altered integrity within each
organ and also lacks standardisation [9]. Additionally,
external factors including gastrointestinal motility and
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mucosal blood flow may lead to inaccuracy of perme-
ability measurements.
The eponymously named Ussing chamber takes its
name from Danish biologist Hans Ussing, who devel-
oped the technique in the 1950s to understand the
phenomenon of active Na+ transport [10]. Such sem-
inal studies paved the way for the present models of
transepithelial transport, including the discovery of
the Na+/K+ ATPase pump [11, 12]. In later years, the
Ussing system helped unravel the mechanistic pro-
cesses underpinning cystic fibrosis (CF). By monitor-
ing ionic movements it was shown that Cl− secretion
was decreased in patients [13–15], due to a mutated
CFTR gene [16].
The Ussing system offers an ex vivo measurement of
permeability using fluorescent probes as well as electro-
physiological measurements. The system design has
been updated to accommodate multiple chambers as
shown in Fig. 1a. The chambers support epithelial tissue
or cell monolayers in such a way that each side of the
membrane is isolated and faces a separate chamber-half.
The potential difference (PD) across epithelial tissue can
be determined using Ag/AgCl electrodes, giving an indi-
cator of tissue health [17]. Transepithelial resistance
(TER) can be calculated to give an overall measurement
of gut integrity. A low TER value is indicative of in-
creased permeability. Short circuit current (Isc) is also
often used during electrophysiological measurements.
Isc refers to the current that is required to nullify tissue
PD and is a summation of all ionic currents across the
epithelium. Isc can be calculated from PD and TER
values. Prior studies have shown that decreased TER
under inflammatory conditions was associated with
down regulation of “sealing” TJ proteins e.g. ZO-1 [18],
JAM-A [19] and claudins-1 [20], − 3 and − 5 [21] as well
as up-regulation of pore forming proteins (claudin-2
[22]). The use of fluorescently labelled probes such as 4
kDa FITC-dextran and lucifer yellow provide measure-
ments of paracellular flux across the epithelium. We de-
scribe in depth the modern multi-chambered Ussing
system, with complementary software protocol. Further-
more, we detail essential methods for dissecting and
mounting tissue samples to ensure both viability and
consistency of results. Methods are illustrated using co-
lonic tissue from mouse models of intestinal inflamma-
tion and human samples.
Methods
Buffers
Krebs buffers are summarised in Table 1. All chemicals
were purchased from Sigma Aldrich, UK. Transport
Krebs, mannitol Krebs and glucose Krebs were used at
pH 7.3, set after buffers were oxygenated.
Mice
C57BL/6-FoxP3DTR mice gifted by Alexander Rudensky,
described by Kim et al. [23] were housed in filter top
cages at the specific pathogen free (SPF) Joint Biological
Service Unit (Cardiff University, UK). All experiments
were performed in the home cage. Mice were main-
tained at a constant temperature, with 12-h light/dark
cycle and had access to standard mouse chow and water
ad libitium. All experiments performed were ethically
approved by the UK Home Office, in accordance with
the Animal Scientific Procedures Act 1986, in compli-
ance with UK Home Office regulations and were carried
out by individuals holding a UK personal home office li-
cence. All mice were monitored daily and humanely
sacrificed by exposure to a rising concentration of 2–4%
CO2, before gut integrity was measured. The National
Centre for the Replacement, Refinement and Reduction
of Animals in Research (NC3Rs) handling guidelines
were also followed within this study. An animal research:
reporting of in-vivo experiments (ARRIVE) guidelines
checklist for working with animals can be found in
Additional file 2.
4 male and 4 female 13–16-week-old C57BL/6-
FoxP3DTR mice were used to demonstrate baseline mea-
surements. Results are comprised of four individual ex-
periments due to constraints relating to Ussing chamber
size. To deplete T regulatory cells (Tregs), diphtheria
toxin (DTx; Native Antigen, UK) in 300 μL PBS was ad-
ministered by standard intraperitoneal (i.p.) injection
(15 μg/kg body weight) to three female C57BL/6-
FoxP3DTR healthy 16-week-old mice, chosen at random,
every other day for 15 days. Three age and sex-matched
mice were used as untreated controls. Treated and un-
treated animals were housed in the same cage.
Medium weight dextran sodium sulphate (DSS) (MP
Biomedicals, UK) is widely used as a model of intestinal
disease [24]. 3% DSS was given to eight healthy 10-
week-old Treg replete female C57BL/6-FoxP3DTR mice,
chosen at random, in drinking water for up to 9 days to
induce acute inflammation. Individual mice were housed
in separate cages to monitor the intake of drinking
water. Four age and sex-matched mice were in the un-
treated control group. Results are comprised of five in-
dependent experiments due to the size of the Ussing
chamber.
Setup of chambers
The Navicyte heating block was used for all experiments.
It accommodates six acrylic chambers and is connected
to a circulating water bath (Harvard Apparatus, UK)
(Fig. 1a) to maintain chambers at 37 °C. Chambers were
cleaned with RBS buffer 25 (Sigma Aldrich, UK) in hot
water using a small toothbrush and dried before use.
Inner surfaces of chamber halves (Fig. 1b) were coated
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with a medium, even layer of vacuum grease (Sigma Al-
drich, UK) using a cotton bud. X-ray film squares with
the correct aperture size to accommodate the required
tissue specimen were made using a hole punch and
placed over chamber pins. Chamber halves were con-





Fig. 1 Design of the Ussing chamber system. a Navicyte Ussing system unit supporting six chambers with custom made electrical manifold. b
Chamber halves showing metal pins used to secure tissue. Gas flow direction to stir buffer is depicted by arrows. c Individual Ussing chamber
with voltage and current Ag/AgCl electrodes. d Birds-eye view of individual Ussing chamber showing electrode and gas inserts. e Amplifying
EC825A voltage clamp box containing a volt and amp meter to record voltage and current respectively. External timer is selected to connect to
computer software. Figures are original, created using Microsoft PowerPoint for Mac version 16.20
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Table 1 Krebs buffers and concentrations
Buffer Concentration
Krebs Stock 136 mM NaCl, 1.5 mM CaCl2*2H2O, 4.3 mM KCl, 1.6 mM KH2PO4, 27 mM NaHCO3, 1.4 mM MgSO4*7H2
Glutamate Stock 114 mM Glutamate
Sodium Pyruvate Stock 115 mM Sodium Pyruvate
Glucose Stock 200 mM Glucose
Mannitol Stock 200 mM Mannitol
Transport Krebs 115.6 mM NaCl, 1.3 mM CaCl2*2H2O, 3.7 mM KCl, 1.4 mM KH2PO4, 23 mM NaHCO3, 1.2 mM MgSO4*7H2
Glucose Krebs 5.8 mM Sodium Pyruvate, 5.7 mM Glutamate, 10 mM Glucose




Fig. 2 Mouse dissection and mounting technique. a Midline incision showing exposed abdominal organs. Black dotted lines indicate dissection points
to obtain the intestine during the procedure. b Colon is flushed with Krebs buffer and opened longitudinally into a flat sheet using micro-dissecting
scissors. X-ray film squares with the desired aperture are applied to the proximal, mid or distal regions. A second x-ray film with corresponding aperture
size is placed on top, sandwiching tissue in-between. c Human biopsy sample showing contraction of serosal tissue leads to formation of a
crescent morphology with the mucosal surface facing upwards. Figures are original, created using Microsoft PowerPoint for Mac version 16.20
Thomson et al. BMC Gastroenterology           (2019) 19:98 Page 4 of 14
AB
C
Fig. 3 Electrical measurements. a Current pulse stimulation event protocol created in LabChart software. b Diagram showing current stimulation
traces and tissue PD response. c Least fit squares analysis based on Ohms law. Current stimulation is plotted against tissue voltage. Linear regression is
equal to TER. The y-intercept equals the PD value of tissue and Isc can be calculated by PD/TER
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using circlip pliers (Harvard Apparatus, UK). 1.5 ml
transport Krebs buffer was added to each side of the
chamber.
Setup of ag/AgCl electrodes
Electrodes arrived in a “ready to use” state, having been
previously coated with AgCl (Harvard Apparatus, UK).
It is essential to re-chloride electrodes to maintain stable
measurements. After experiments, old AgCl coating was
removed from electrodes by gently rubbing with steel
wool. Electrodes were cleaned with dH2O and immersed
in household bleach for 24–48 h before the beginning of
experiments to ensure efficient chloriding of the silver
wire. Electrodes were washed with dH2O before use.
Note that poor chloriding of electrodes will result in
drifting PD values during the initial setup, making it
impossible to zero any offset potential before tissue
collection.
3M KCl saturated with Ag electrolyte solution (Sigma
Aldrich, UK) was dispensed into a small bottle contain-
ing a holder for a thin plastic tube. The tube was
inserted to the end of the electrode glass barrel (Harvard
Apparatus, UK) where a ceramic junction is located.
Using constant pressure, in order that electrolyte solu-
tion flows continually, the barrel is filled as the tube is
slowly withdrawn. Tapping lightly against the ceramic
junction dislodges micro air bubbles. KCl salt can form
at the opening of the glass barrel. This was carefully re-
moved to prevent blockages of the ceramic junction,
which can lead to interference or obstruction of elec-
trical readings. Note that air bubbles and blockage of the
ceramic junction are the most common reason for poor
A B
C D
Fig. 4 Baseline TER identifies regional permeability differences. a TER of mid and distal colonic regions normalised to the proximal colonic region
from individual untreated FoxP3DTR mice. b Negative PD values showing tissue responds to Forskolin at sixty minutes. c Isc values. d Tissue with
a negative PD value shows little or no 4 kDa FITC-dextran in serosal chamber. Black triangles indicate tissue not responsive to forskolin, therefore
removed from further analyses. Student’s unpaired t-test, statistical significance is indicated: *p = < 0.05. Error bars show +/− SEM




Fig. 5 (See legend on next page.)
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electrical readings. Glass barrels should be replaced if
necessary. Electrodes were assembled and positioned to
be close to each other but not touching within the
chamber (Fig. 1c and d). Current pulses were sent across
the chamber using an EC825A volt/clamp box (Warner
Instruments Inc., Connecticut, USA) (Fig. 1e) to meas-
ure the resistance created by the buffer and presence of
x-ray film pieces (see Electrical measurements). During
analysis the “buffer resistance” was subtracted from total
resistance readings.
Murine dissection technique and mounting
A midline incision was made, and the colon dissected
from the small intestine by cutting across the bottom
half of the caecum (Fig. 2a). Faecal contents were re-
moved by flushing with oxygenated transport Krebs buf-
fer (Fig. 2b). The colon was pinned onto a cold sylgard
plate (Ellsworth Adhesives, East Kilbride, Scotland) and
opened longitudinally using watch-maker forceps and
micro-dissection scissors (Fig. 2b). Desired colonic sec-
tions were selected with x-ray film squares that exhibit a
3 mm diameter hole and subsequently mounted onto
chamber pins (Fig. 2b). Corresponding x-ray film
squares were placed on top, sandwiching tissue in-
between to prevent leakage. 1.5 ml cold oxygenated
transport Krebs buffer was gently added to each
chamber-half, avoiding dislodging the tissue. Chambers
were placed on ice and transported to the laboratory
within 10 minutes. Note that any damage to the mucosal
surface will result in poor readings.
Human biopsy collection and mounting
Colonic biopsies were obtained from 17 patients under-
going colonoscopy procedures at The University Hos-
pital of Wales (patient characteristics are given in
Additional file 1: Table S1). Prior to colonoscopy, pa-
tients consumed laxatives (Moviprep or Citramag and
Senna), following Cardiff and Vale health board instruc-
tions. All subjects gave informed consent to take part in
this study. The Wales Research Ethics Committee
granted ethical approval (15/WA/0291). Approximately
six biopsies from each patient were obtained using oval
fenestrated non-spiked swing jaw disposable forceps
(Olympus, UK). Note that spiked forceps would punc-
ture tissue samples. Biopsies were immediately put into
cold oxygenated transport Krebs buffer and transported
to the laboratory within 10 minutes. Whilst remaining
immersed in cold oxygenated transport Krebs buffer, bi-
opsies were examined for damage under 5X magnifica-
tion and carefully unfolded. The mucosal surface was
identified as shown in Fig. 2c. Biopsies were mounted
mucosal side up, in-between two pieces of x-ray film
with an aperture size of 0.79 mm2. Chambers were
closed and secured with circlips.
Equilibration of tissue
Serosal chamber-halves were filled with 1.5 ml cold glu-
cose Krebs buffer (10 mM) to provide tissue with an en-
ergy source. Mucosal halves were filled with 1.5 ml cold
mannitol Krebs buffer (10 mM) to maintain osmotic bal-
ance without influencing glucose mediated Na+ trans-
port. Electrodes were inserted as shown in Fig. 1c and d
to monitor PD values. Chambers were warmed to 37 °C
via the circulating water bath and continuously oxygen-
ated with 95% O2, 5% CO2 to aid tissue viability and
provide buffer circulation. Buffers at 37 °C were renewed
after 20 minutes and again at 30 minutes to remove
auto-fluorescent molecules before measurements began.
Fluorescent probe addition
After equilibration, mannitol-krebs was replaced with
150 μl 4 kDa FITC-dextran (Sigma Aldrich, UK. Catalog
number: 46944) during mouse studies or CH dilithium
lucifer yellow during human studies (Sigma Aldrich, UK.
Catalog number: L0259). Starting concentrations of 0.5
mg/ml or 1 mg/ml 4 kDa FITC-dextran were used. Initial
experiments revealed that 4 kDa FITC-dextran was not
easily detected within healthy mouse tissue. Therefore,
the smaller probe lucifer yellow (457 Da) was chosen for
human studies. Lucifer yellow was added at 250 μg/
ml. Paired mucosal and serosal samples were obtained
at 60 minutes and fluorescence analysed on the Clar-
iostar plate reader (BMG, Germany). Serosal concen-
trations were determined using a standard curve
generated from known concentrations. Paracellular
flux is given as μg/ml/cm2.
Electrical measurements
Spontaneous tissue potential difference (PD) was mea-
sured continuously throughout experiments via voltage
Ag/AgCl electrodes. Experiments were performed in
open circuit conditions where short current pulses of
1.5, − 1.5, 3 and -3 μA with a duration of 240ms were
sent across the tissue every 5 minutes via Ag/AgCl
(See figure on previous page.)
Fig. 5 3% Dextran Sodium Sulphate causes intestinal inflammation and increased intestinal permeability. 10-week-old mice were administered
3% DSS within drinking water for up to nine days to induce acute intestinal inflammation. a Percentage body weight and (b) colon length of animals.
c Representative haematoxylin and eosin immunohistochemistry staining of colonic tissue. Asterisks and arrows indicate increased immune cell
infiltration and disrupted crypt structure respectively. d TER measurements of proximal colon from DSS treated and untreated animals. e 4 kDa FITC-
dextran flux across colonic tissue. n = 4 untreated vs 8 treated. Error bars show +/− SEM





Fig. 6 (See legend on next page.)
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current passing electrodes (current clamping). Current
stimulation was generated from an EC825A voltage/
clamp unit (Fig. 1e), controlled by a LabChart software
protocol developed in-house (Fig. 3a). The PD response
to a fixed “clamped” current was measured at each
stimulation event and mean voltage response of four re-
cordings calculated (Fig. 3b). Tissue TER was calculated
using a linear least squares fit analysis based on Ohms
Law: resistance (R) = voltage (V) / current (I). TER is
equal to the slope of the line generated and resting tis-
sue PD equal to the intersection of the Y-axis. Isc was
not directly monitored in this study but can be calcu-
lated by PD/TER. (Fig. 3c). TER is given as Ω (ohms)
*cm2 by multiplying by the exposed tissue area. At 60
minutes, the cAMP-dependent Cl− secretagogue forsko-
lin (Sigma Aldrich, UK) was added to the serosal cham-
ber at a final concentration of 6.6 μM to evaluate tissue
viability. Only samples with a PD value of 0.5 mV or less
and a response to forskolin, as shown by a drop in PD
were included in analyses. A forskolin response can also
be identified by an increase in Isc.
Histological analysis
Mouse colonic tissue was wrapped around a large pair
of forceps to create a “gut roll” and pinned in place with
a 23G needle. Samples were fixed in 10% neutral buff-
ered formalin solution (NBFS) (Sigma Aldrich, UK) for
approximately 7 days then put into 70% ethanol. For hu-
man biopsy samples 10% NBFS was added directly to
chambers upon completion of Ussing experiments for 2
days. Samples were removed and placed in universals
containing 10% NBFS for a further 24 h before being
transferred into 70% ethanol. Samples were agar embed-
ded to ensure correct orientation of the tissue before be-
ing processed and embedded into paraffin wax blocks.
5 μm sections were cut and stained with Harris haema-
toxylin (Sigma Aldrich, UK) and eosin Y solution (Sigma
Aldrich, UK).
Statistical analysis
GraphPad Prism version 5 was used for all statistical
analyses. Groups were assessed for normal distribution.
A student’s T test or Mann Whitney test was applied to
test for statistically significant differences. A P-value
≤0.05 was considered significant.
Results
Regional variation of intestinal integrity occurs within
healthy mice
Regional variations of intestinal integrity are not well de-
fined. Therefore the TER across proximal, mid and distal
colonic sections from untreated FoxP3DTR mice was in-
vestigated using the Ussing chamber system. Male and
female mice show TER is lowest in the mid-section of
the colon and highest in the proximal region (Fig. 4a),
thus the mid-region of the colon is naturally most per-
meable. Comparing TER between male and female mice,
there was no significant difference (Additional file 3: Fig-
ure S1A-S1C). A trend for lower TER in the mid colonic
region of female mice was observed (Additional file 3:
Figure S1B). Addition of forskolin to chambers resulted
in a drop in PD (Fig. 4b) mirrored by an increase in Isc
(Fig. 4c). Mucosal integrity was confirmed by lack of 4
kDa FITC-dextran passage (Fig. 4d).
Measuring intestinal permeability in chemical-induced
colitis
DSS induces intestinal inflammation (colitis) in mice
[24]. Addition of 3% DSS to drinking water leads to re-
duction in mouse weight (Fig. 5a) and shortening of
colon length (Fig. 5b) within 9 days. This was associated
with disruption of normal epithelial intestinal architec-
ture of the colon (Fig. 5c). Ussing chamber analysis of
proximal colonic regions showed reduced TER (Fig. 5d)
and increased paracellular flux of 4 kDa FITC-dextran
(Fig. 5e). Together these data demonstrate increased in-
testinal permeability with DSS-induced colitis.
Measuring intestinal permeability in auto-immune colitis
Tregs are a major component of the immune system, re-
sponsible for controlling immune responses, reducing in-
flammation and promoting tolerance towards commensal
microbiota and food antigens within the intestine [25–28].
Depletion of Tregs (Fig. 6a) causes the development of
autoimmune symptoms, including colitis (weight loss and
diarrhoea) [29]. Treg-depleted mice were sacrificed once
signs of autoimmunity (piloerection, scaly skin, listless be-
havior) were evident and gut integrity assessed. In com-
parison to untreated controls, Treg-depleted mice
exhibited weight loss by day 14 (Fig. 6b). This was not ac-
companied by shortening of colon length (Fig. 6c). De-
pleted mice had abnormal colonic architecture, indicative
(See figure on previous page.)
Fig. 6 T-regulatory cell depleted mice (DTx) show increased intestinal permeability. a Representative FACS plots showing depletion of FoxP3+
cells. b Percentage body weight and (c) colon length of untreated and treated mice. d Haematoxylin and eosin staining of distal colonic sections
from untreated and treated animals. Asterisks and arrows indicate increased immune cell infiltration and disrupted crypt structure respectively.
e TER and (f) 4 kDa FITC-dextran passage of proximal and mid colonic sections. Mucosal starting concentration was 1 mg/ml. n = 3 treated vs 3
untreated 16-week-old female mice. Unpaired students T tests and a Mann Whitney test were used for comparisons in (e) and (f) respectively.
Significant differences indicate: *P < 0.05, **P < 0.001, ***P < 0.001. Error bars show +/− SEM
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of inflammation (Fig. 6d), and displayed a reduction in
TER (Fig. 6e). TER also declined rapidly, suggesting that
removal of Tregs reduces the tissue’s ability to maintain
efficient tight junctional structures under stress. The fall
in TER was accompanied by increased 4 kDa FITC-
dextran paracellular flux (Fig. 6f). Collectively, these data
indicate that Tregs have a role in promoting gut integrity
and maintaining intestinal homeostasis.
Human biopsy intestinal permeability
Human biopsy samples can be examined in Ussing





Fig. 7 Human permeability measurements. a TER of paired right and left colon biopsies from control patients. b TER and (c) lucifer yellow
passage of right and left colon biopsies taken from control patients or from a lesion site. d Haematoxylin and eosin staining of control tissue or
tissue from a lesion site. Asterisks and arrows indicate increased immune cell infiltration and disrupted crypt structure respectively. Unpaired two-
tailed students T-test and Mann-Whitney tests used for statistical analyses. Error bars show +/− SEM
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lower TER than the right (Fig. 7a). This variation has
not been shown previously in humans and replicates re-
gional changes observed in mice (Fig. 4a). Mucosal biop-
sies obtained from a lesion site (within 1 cm of an
adenomatous polyp or tumour tissue) showed consider-
ably reduced TER in comparison to samples from
healthy individuals (Fig. 7b). There is a higher flux of the
paracellular probe lucifer yellow in left sided colonic bi-
opsies compared to right sided samples from healthy pa-
tients (Fig. 7c). Lucifer yellow provided a more sensitive
measurement of paracellular permeability than 4 kDa
FITC-dextran due to its smaller size of 457 Da. Lucifer
yellow flux was notably higher in lesion sites when com-
pared to biopsies from the right colon, but was compar-
able with a proportion of left colon biopsies (mean =
19.67 μg/ml/cm2 vs 15.2 μg/ml/cm2, respectively). Add-
itional file 4: Figure S2A and B show there is a signifi-
cant correlation between lucifer yellow flux and TER in
the right colon but not in the left (Additional file 4).
This supports the fact that lucifer yellow measures only
paracellular flux. TER provides an overall permeability
reading, taking into account all routes of passage includ-
ing those created by ionic pores and upregulation/down-
regulation of TJ proteins.
Discussion
This report describes methodology to measure intestinal
permeability of mouse and human colonic samples ex vivo
using the Ussing chamber system. Intestinal epithelial bar-
rier function is crucial for maintaining a symbiotic rela-
tionship between the body and commensal microbiota
that reside within it. The ability to measure this function
is a useful addition to studying gastrointestinal physiology,
pharmacology, and disease. The Ussing system can be
adapted in-house to support various tissue sizes and is
capable of identifying subtle differences in gut integrity at
various regions of the colon, including sections of colon
surrounding intestinal abnormalities. Historically surgical
samples were used but they may become ischaemic if
there are delays in collection and require seromuscular
stripping (to remove smooth muscle) +/− indomethacin
(inhibits tissue cyclooxygenases to prevent the production
of inflammatory prostaglandins). It is far more straightfor-
ward to use fresh mucosal biopsies obtained during en-
doscopy. By using a six-chamber system, sub-optimal
biopsies (abnormal PD value or unresponsive to forskolin)
can be discounted from analyses and the remaining sam-
ples used to calculate integrity. We demonstrate the reli-
ability and consistency of Ussing chamber measurements
and importantly describe regional variation in colonic per-
meability. Nevertheless, differences are suggested by em-
bryological origins of hind vs midgut [30], different
patterns of disease distribution seen in IBD [31] and ex-
pression patterns of TJ proteins [32].
Optimisation of dissection techniques for both mouse
and human tissue is important for viability. In this study,
experiments ran for a total of ninety minutes, with for-
skolin addition at sixty minutes. Lengthier experiments
are possible (up to 3 h) but tissue viability has to be
demonstrated throughout the experimental procedure.
Simultaneous electrical and probe flux measurements
provide a detailed description of intestinal integrity. Of
note, passage of 4 kDa FITC-dextran and other para-
cellular probes such as 51Cr-EDTA show a linear in-
crease over time [33]. Validation of this Ussing chamber
system was achieved through measurements using
mouse models of chemically and autoimmune induced
inflammation. The data described in this report demon-
strates for the first time that depletion of Tregs results
in reduction of epithelial barrier function, a key aspect
in the generation of colitis [29].
Once Ussing chamber methodology is established
there are many experimental applications of the tech-
nique, such as measuring how drugs or exogenous cyto-
kines impact on permeability or the effect of the
microbiome on intestinal function. Furthermore, it can
give insight into differing disease states of the alimentary
canal. The methodology described within this report
should enable those new to the field to construct an
Ussing chamber system and obtain reliable measure-
ments of intestinal permeability.
Conclusions
The Ussing Chamber system is a useful tool for assessing
gut integrity within animal models and humans. How-
ever, setup of equipment and methodology can be chal-
lenging. This study provides detailed information on
Ussing Chamber equipment, experimental procedures
and results that validate the technique. Importantly this
report provides step-by-step detailed information, there-
fore it can be utilised by scientists from various sub-
specialties.
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